Bibliography

Export 17 results:
Filters: Author is Gross,T. G.  [Clear All Filters]
2006
Husted TL, Neff G, Thomas MJ, Gross TG, Woodle ES, Buell JF. Liver transplantation for primary or metastatic sarcoma to the liver. Am J Transplant. 2006;6(2):392-7.
2005
Trofe J, Buell JF, Beebe TM, Hanaway MJ, First MR, Alloway RR, et al. Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience. Am J Transplant. 2005;5(4 Pt 1):775-80.
Buell JF, Gross TG, Hanaway MJ, Trofe J, Muthiak C, First MR, et al. Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):956-7.
Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation. 2005;80(2 Suppl):S254-64.
Buell JF, Gross TG, Hanaway MJ, Trofe J, Roy-Chaudhury P, First MR, et al. Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. Transplant Proc. 2005;37(2):954-5.
Woodle ES, Gupta M, Buell JF, Neff GW, Gross TG, First MR, et al. Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):958-9.
Buell JF, Beebe TM, Gross TG, Trofe J, Hanaway MJ, Alloway RR, et al. United network for organ sharing publication on scientific registry of transplant recipients central nervous system donor cancer transmission data. Transplantation. 2005;79(5):623.
2004
Papaconstantinou HT, Sklow B, Hanaway MJ, Gross TG, Beebe TM, Trofe J, et al. Characteristics and survival patterns of solid organ transplant patients developing de novo colon and rectal cancer. Dis Colon Rectum. 2004;47(11):1898-903.
Buell JF, Beebe TM, Trofe J, Gross TG, Alloway RR, Hanaway MJ, et al. Donor transmitted malignancies. Ann Transplant. 2004;9(1):53-6.
Aull MJ, Buell JF, Trofe J, First MR, Alloway RR, Hanaway MJ, et al. Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry. Transplantation. 2004;78(11):1676-82.
Trofe J, Beebe TM, Buell JF, Hanaway MJ, First MR, Alloway RR, et al. Posttransplant malignancy. Prog Transplant. 2004;14(3):193-200.
Trofe J, Buell JF, Woodle ES, Beebe TM, Hanaway MJ, First MR, et al. Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma. Transplantation. 2004;78(7):972-7.
2003
Buell JF, Trofe J, Sethuraman G, Hanaway MJ, Beebe TM, Gross TG, et al. Donors with central nervous system malignancies: are they truly safe? Transplantation. 2003;76(2):340-3.
Witherow BA, Roth GS, Carrozza MA, Freyberg RW, Kopke JE, Alloway RR, et al. The Israel Penn International Transplant Tumor Registry. AMIA Annu Symp Proc. 2003:1053.
2002
Buell JF, Hanaway MJ, Trofe J, Gross TG, Beebe TM, Alloway RR, et al. De novo breast cancer in renal transplant recipients. Transplant Proc. 2002;34(5):1778-9.
Buell JF, Trofe J, Hanaway MJ, Beebe TM, Gross TG, Alloway RR, et al. Immunosuppression and Merkel cell cancer. Transplant Proc. 2002;34(5):1780-1.
Buell JF, Husted T, Hanaway MJ, Peddi VR, Trofe J, Gross TG, et al. Incidental diagnosis of gastric cancer in transplant recipients improves patient survival. Surgery. 2002;132(4):754-8; - discussion - 758-60.